aluates Reports

$ 0.0

Automative

Global Diabetes Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Published Date: August 2025

Report Code: QYRE-Auto-4B14286

Global Diabetes Stem Cell Therapy Market Research Report 2023

BUY CHAPTERS

Global Diabetes Stem Cell Therapy Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Code: QYRE-Auto-4B14286

Report

August 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sernova

Vertex Pharmaceuticals

CRISPR Therapeutics

Eli Lilly

CellTrans

Seraxi

iTolerance

Diabetes Stem Cell Therapy Sales Market Size

The global Diabetes Stem Cell Therapy market size was US$ 127 million in 2024 and is forecast to a readjusted size of US$ 3180 million by 2031 with a CAGR of 59.3% during the forecast period 2025-2031.

Diabetes Stem Cell Therapy Sales Market

North America key players of Diabetes Stem Cell Therapy include CellTrans, Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, etc. The top five players hold a share about 100%.

The global Diabetes Stem Cell Therapy market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

Market Segmentation

Scope of Diabetes Stem Cell Therapy Sales Market Report

Report Metric	Details
Report Name	Diabetes Stem Cell Therapy Sales Market
Forecasted market size in 2031	US$ 3180 million
CAGR	59.3%
Forecasted years	2025 - 2031
By Type: (Dominant Segment vs High-Margin Innovation)	Preclinical Clinical Phase
By Application: (Core Demand Driver vs Emerging Opportunity)	Type 1 Diabetes Type 2 Diabetes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company:	Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, Sernova, Eli Lilly, CellTrans
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Diabetes Stem Cell Therapy market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Clinical Phase in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Type 2 Diabetes in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Diabetes Stem Cell Therapy value chain, addressing:

FAQ for this report

What is the Diabetes Stem Cell Therapy Sales Market size in 2031?

Ans: The Diabetes Stem Cell Therapy Sales Market size in 2031 will be US$ 3180 million.

What is the market share of major companies in Diabetes Stem Cell Therapy Sales Market?

Ans: The top five players hold a share about 100%.

Who are the main players in the Diabetes Stem Cell Therapy Sales Market report?

Ans: The main players in the Diabetes Stem Cell Therapy Sales Market are Seraxi, Vertex Pharmaceuticals, CRISPR Therapeutics, iTolerance, Sernova, Eli Lilly, CellTrans

What are the Application segmentation covered in the Diabetes Stem Cell Therapy Sales Market report?

Ans: The Applications covered in the Diabetes Stem Cell Therapy Sales Market report are Type 1 Diabetes, Type 2 Diabetes

What are the Type segmentation covered in the Diabetes Stem Cell Therapy Sales Market report?

Ans: The Types covered in the Diabetes Stem Cell Therapy Sales Market report are Preclinical, Clinical Phase

Recommended Reports

Stem Cell Therapy

Diabetes Therapeutics

Cellular Therapy Market

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Preclinical

1.2.3 Clinical Phase

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Type 1 Diabetes

1.3.3 Type 2 Diabetes

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Diabetes Stem Cell Therapy Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Diabetes Stem Cell Therapy Revenue Market Share by Region (2020-2025)

2.4 Global Diabetes Stem Cell Therapy Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Diabetes Stem Cell Therapy Market Size and Prospective (2020-2031)

2.5.2 Europe Diabetes Stem Cell Therapy Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Diabetes Stem Cell Therapy Historic Market Size by Type (2020-2025)

3.2 Global Diabetes Stem Cell Therapy Forecasted Market Size by Type (2026-2031)

3.3 Different Types Diabetes Stem Cell Therapy Representative Players

4 Breakdown Data by Application

4.1 Global Diabetes Stem Cell Therapy Historic Market Size by Application (2020-2025)

4.2 Global Diabetes Stem Cell Therapy Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Diabetes Stem Cell Therapy Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Diabetes Stem Cell Therapy Players by Revenue (2020-2025)

5.1.2 Global Diabetes Stem Cell Therapy Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Diabetes Stem Cell Therapy Revenue

5.4 Global Diabetes Stem Cell Therapy Market Concentration Analysis

5.4.1 Global Diabetes Stem Cell Therapy Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Diabetes Stem Cell Therapy Revenue in 2024

5.5 Global Key Players of Diabetes Stem Cell Therapy Head office and Area Served

5.6 Global Key Players of Diabetes Stem Cell Therapy, Product and Application

5.7 Global Key Players of Diabetes Stem Cell Therapy, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Diabetes Stem Cell Therapy Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Diabetes Stem Cell Therapy Market Size by Type (2020-2025)

6.1.2.2 North America Diabetes Stem Cell Therapy Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Diabetes Stem Cell Therapy Market Size by Application (2020-2025)

6.1.3.2 North America Diabetes Stem Cell Therapy Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Diabetes Stem Cell Therapy Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Diabetes Stem Cell Therapy Market Size by Type (2020-2025)

6.2.2.2 Europe Diabetes Stem Cell Therapy Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Diabetes Stem Cell Therapy Market Size by Application (2020-2025)

6.2.3.2 Europe Diabetes Stem Cell Therapy Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

7 Key Players Profiles

7.1 Seraxi

7.1.1 Seraxi Company Details

7.1.2 Seraxi Business Overview

7.1.3 Seraxi Diabetes Stem Cell Therapy Introduction

7.1.4 Seraxi Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.1.5 Seraxi Recent Development

7.2 Vertex Pharmaceuticals

7.2.1 Vertex Pharmaceuticals Company Details

7.2.2 Vertex Pharmaceuticals Business Overview

7.2.3 Vertex Pharmaceuticals Diabetes Stem Cell Therapy Introduction

7.2.4 Vertex Pharmaceuticals Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.2.5 Vertex Pharmaceuticals Recent Development

7.3 CRISPR Therapeutics

7.3.1 CRISPR Therapeutics Company Details

7.3.2 CRISPR Therapeutics Business Overview

7.3.3 CRISPR Therapeutics Diabetes Stem Cell Therapy Introduction

7.3.4 CRISPR Therapeutics Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.3.5 CRISPR Therapeutics Recent Development

7.4 iTolerance

7.4.1 iTolerance Company Details

7.4.2 iTolerance Business Overview

7.4.3 iTolerance Diabetes Stem Cell Therapy Introduction

7.4.4 iTolerance Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.4.5 iTolerance Recent Development

7.5 Sernova

7.5.1 Sernova Company Details

7.5.2 Sernova Business Overview

7.5.3 Sernova Diabetes Stem Cell Therapy Introduction

7.5.4 Sernova Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.5.5 Sernova Recent Development

7.6 Eli Lilly

7.6.1 Eli Lilly Company Details

7.6.2 Eli Lilly Business Overview

7.6.3 Eli Lilly Diabetes Stem Cell Therapy Introduction

7.6.4 Eli Lilly Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.6.5 Eli Lilly Recent Development

7.7 CellTrans

7.7.1 CellTrans Company Details

7.7.2 CellTrans Business Overview

7.7.3 CellTrans Diabetes Stem Cell Therapy Introduction

7.7.4 CellTrans Revenue in Diabetes Stem Cell Therapy Business (2020-2025)

7.7.5 CellTrans Recent Development

8 Diabetes Stem Cell Therapy Market Dynamics

8.1 Diabetes Stem Cell Therapy Industry Trends

8.2 Diabetes Stem Cell Therapy Market Drivers

8.3 Diabetes Stem Cell Therapy Market Challenges

8.4 Diabetes Stem Cell Therapy Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sernova

Vertex Pharmaceuticals

CRISPR Therapeutics

Eli Lilly

CellTrans

Seraxi

iTolerance

List of Tables

Table 1. Global Diabetes Stem Cell Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Diabetes Stem Cell Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Diabetes Stem Cell Therapy Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Diabetes Stem Cell Therapy Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Diabetes Stem Cell Therapy Revenue Share by Region (2020-2025)

Table 6. Global Diabetes Stem Cell Therapy Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Diabetes Stem Cell Therapy Revenue Share Forecast by Region (2026-2031)

Table 8. Global Diabetes Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Diabetes Stem Cell Therapy Revenue Market Share by Type (2020-2025)

Table 10. Global Diabetes Stem Cell Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Diabetes Stem Cell Therapy Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Diabetes Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Diabetes Stem Cell Therapy Revenue Market Share by Application (2020-2025)

Table 15. Global Diabetes Stem Cell Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Diabetes Stem Cell Therapy Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Diabetes Stem Cell Therapy Application

Table 18. Global Diabetes Stem Cell Therapy Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Diabetes Stem Cell Therapy Market Share by Players (2020-2025)

Table 20. Global Top Diabetes Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Stem Cell Therapy as of 2024)

Table 21. Ranking of Global Top Diabetes Stem Cell Therapy Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Diabetes Stem Cell Therapy Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Diabetes Stem Cell Therapy, Headquarters and Area Served

Table 24. Global Key Players of Diabetes Stem Cell Therapy, Product and Application

Table 25. Global Key Players of Diabetes Stem Cell Therapy, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Diabetes Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Diabetes Stem Cell Therapy Revenue Market Share by Company (2020-2025)

Table 29. North America Diabetes Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Diabetes Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Diabetes Stem Cell Therapy Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Diabetes Stem Cell Therapy Revenue Market Share by Company (2020-2025)

Table 33. Europe Diabetes Stem Cell Therapy Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Diabetes Stem Cell Therapy Market Size by Application (2020-2025) & (US$ Million)

Table 35. Seraxi Company Details

Table 36. Seraxi Business Overview

Table 37. Seraxi Diabetes Stem Cell Therapy Product

Table 38. Seraxi Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 39. Seraxi Recent Development

Table 40. Vertex Pharmaceuticals Company Details

Table 41. Vertex Pharmaceuticals Business Overview

Table 42. Vertex Pharmaceuticals Diabetes Stem Cell Therapy Product

Table 43. Vertex Pharmaceuticals Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 44. Vertex Pharmaceuticals Recent Development

Table 45. CRISPR Therapeutics Company Details

Table 46. CRISPR Therapeutics Business Overview

Table 47. CRISPR Therapeutics Diabetes Stem Cell Therapy Product

Table 48. CRISPR Therapeutics Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 49. CRISPR Therapeutics Recent Development

Table 50. iTolerance Company Details

Table 51. iTolerance Business Overview

Table 52. iTolerance Diabetes Stem Cell Therapy Product

Table 53. iTolerance Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 54. iTolerance Recent Development

Table 55. Sernova Company Details

Table 56. Sernova Business Overview

Table 57. Sernova Diabetes Stem Cell Therapy Product

Table 58. Sernova Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 59. Sernova Recent Development

Table 60. Eli Lilly Company Details

Table 61. Eli Lilly Business Overview

Table 62. Eli Lilly Diabetes Stem Cell Therapy Product

Table 63. Eli Lilly Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 64. Eli Lilly Recent Development

Table 65. CellTrans Company Details

Table 66. CellTrans Business Overview

Table 67. CellTrans Diabetes Stem Cell Therapy Product

Table 68. CellTrans Revenue in Diabetes Stem Cell Therapy Business (2020-2025) & (US$ Million)

Table 69. CellTrans Recent Development

Table 70. Diabetes Stem Cell Therapy Market Trends

Table 71. Diabetes Stem Cell Therapy Market Drivers

Table 72. Diabetes Stem Cell Therapy Market Challenges

Table 73. Diabetes Stem Cell Therapy Market Restraints

Table 74. Research Programs/Design for This Report

Table 75. Key Data Information from Secondary Sources

Table 76. Key Data Information from Primary Sources

List of Figures

Figure 1. Diabetes Stem Cell Therapy Product Picture

Figure 2. Global Diabetes Stem Cell Therapy Market Share by Type: 2024 VS 2031

Figure 3. Preclinical Features

Figure 4. Clinical Phase Features

Figure 5. Global Diabetes Stem Cell Therapy Market Share by Application: 2024 VS 2031

Figure 6. Type 1 Diabetes

Figure 7. Type 2 Diabetes

Figure 8. Diabetes Stem Cell Therapy Report Years Considered

Figure 9. Global Diabetes Stem Cell Therapy Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 10. Global Diabetes Stem Cell Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Diabetes Stem Cell Therapy Revenue Market Share by Region: 2020 VS 2024

Figure 12. North America Diabetes Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)

Figure 13. Europe Diabetes Stem Cell Therapy Revenue (US$ Million) Growth Rate (2020-2031)

Figure 14. Global Diabetes Stem Cell Therapy Market Share by Players in 2024

Figure 15. Global Top Diabetes Stem Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Stem Cell Therapy as of 2024)

Figure 16. The Top 10 and 5 Players Market Share by Diabetes Stem Cell Therapy Revenue in 2024

Figure 17. North America Diabetes Stem Cell Therapy Market Share by Type (2020-2025)

Figure 18. North America Diabetes Stem Cell Therapy Market Share by Application (2020-2025)

Figure 19. Europe Diabetes Stem Cell Therapy Market Share by Type (2020-2025)

Figure 20. Europe Diabetes Stem Cell Therapy Market Share by Application (2020-2025)

Figure 21. Seraxi Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 22. Vertex Pharmaceuticals Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 23. CRISPR Therapeutics Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 24. iTolerance Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 25. Sernova Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 26. Eli Lilly Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 27. CellTrans Revenue Growth Rate in Diabetes Stem Cell Therapy Business (2020-2025)

Figure 28. Bottom-up and Top-down Approaches for This Report

Figure 29. Data Triangulation

Figure 30. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4250

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6375

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8500

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Autologous Stem Cell and Non Stem Cell Based Therapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Diabetes Therapy Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autologous Stem Cell Based Therapies Market Research Report 2024

Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stem Cell Wounds Therapy Market Research Report 2024

Global Cell Therapy CMO Market Research Report 2025

Diabetes Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Type 2 Diabetes Therapeutics Market Research Report 2025

Glycemic Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Stem Cell Hair Transplant Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non Insulin Therapies for Diabetes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Orthopedic Cell Therapy Market Research Report 2024

Global Diabetic Therapeutic Drugs Market Research Report 2025

Global Cellular and Gene Therapy Product Market Research Report 2025

Antidiabetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Combination Anti Diabetes Drugs Market Research Report 2025

Graft Versus Host Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Graft versus host Disease cGVHD Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

CAR T Cell Therapy Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions